Читать книгу Gestational Diabetes - Группа авторов - Страница 70

1American Diabetes Association: Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41(suppl 1):S13–S27.

2O’Sullivan JB, Mahan C: Criteria for oral glucose tolerance test in pregnancy. Diabetes 1964;13:278–285.

3Metzger BE, Coustan DR: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21(suppl 2):B161–B167.

4Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30(suppl 2):S251–S260.

5Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA: Maternal age and screening for gestational diabetes: a population-based study. Obstet Gynecol 1989;73:557–561.

6O’Sullivan JB, Mahan CM, Charles D, Dandrow RV: Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol 1973;116:895–900.

7Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979;28:1039–1057.

8Carpenter MW, Coustan DR: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768–773.

9World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Geneva, World Health Organization, 1999.

10Tallarigo L, Giampietro O, Penno G, Miccoli R, Gregori G, Navalesi R: Relation of glucose tolerance to complications of pregnancy in non-diabetic women. N Engl J Med 1986;315:989–992.

11Langer O, Brustman L, Anyaegbunam A, Mazze R: The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy. Am J Obstet Gynecol 1987;157:758–763.

12Sacks DA, Abu-Fadil S, Greenspoon JS, Fotheringham N: Do the current standards for glucose tolerance testing in pregnancy represent a valid conversion of O’Sullivan’s original criteria? Am J Obstet Gynecol 1989;161:638–641.

13Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JW, Farine D, et al: Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3,637 women without gestational diabetes. Am J Obstet Gynecol 1995;173:146–156.

14Vambergue A, Nuttens MC, Verier-Mine O, Dognin C, Cappoen JP, Fontaine P: Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The Diagest Study. Diabet Med 2000;17:203–208.

15Jensen DM, Damm P, Sorensen B, Molsted-Pedersen L, Westergaard JG, Klebe J, et al: Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2,904 nondiabetic Danish women with risk factors for gestational diabetes. Am J Obstet Gynecol 2001;185:413–419.

16Yang X, Hsu-Hage B, Zhang H, Zhang C, Zhang Y, Zhang C: Women with impaired glucose tolerance during pregnancy have significantly poor pregnancy outcomes. Diabetes Care 2002;25:1619–1624.

17Ferrara A, Weiss NS, Hedderson MM, Quesenberry CP Jr, Selby JV, Ergas IJ, Peng T, Escobar GJ, Pettitt DJ, Sacks DA: Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 2007;50:298–306.

18HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002.

19Pettitt DJ, Knowler WC, Baird HR, Bennett PH: Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 1980;3:458–464.

20Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JW, Farine D, Cohen HR, McArthur K, Holzapfel S, Biringer A: Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes: the Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995;173:146–156.

21Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Mølsted-Pedersen L, Damm P: Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 2008;87:59–62.

22HAPO Cooperative Research Group: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: preeclampsia. Am J Obstet Gynecol 2010;202:255.e1–e7.

23HAPO Study Cooperative Research Group: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009;58:453–459.

24HAPO Study Cooperative Research Group: Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG 2010;117:575–584.

25Catalano PM, McIntyre HD, Cruickshank JK, et la.; HAPO Study Cooperative Research Group: The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 2012;35:780–786.

26Metzger BE, Persson B, Lowe LP, et al.; HAPO Study Cooperative Research Group: Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics 2010;126:e1545–1552.

27McLeod DS, Warner JV, Henman M, et al.; HAPO Study Cooperative Research Group: Associations of serum vitamin D concentrations with obstetric glucose metabolism in a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study cohort. Diabet Med 2012;29:e199–e1204.

28Ackerman CM, Lowe LP, Lee H, et al.; HAPO Study Cooperative Research Group: Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat. J Androl 2012;33:210–215.

29Lowe LP, Metzger BE, Lowe WL Jr, et la.; HAPO Study Cooperative Research Group: Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. J Clin Endocrinol Metab 2010;95:5427–5434.

30Freathy RM, Hayes MG, Urbanek M, et al.; The HAPO Study Cooperative Research Group: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: common genetic variants in GCK and TCF7L2 are associated with fasting and postchallenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from the International Association of Diabetes and Pregnancy Study Groups. Diabetes 2010;59:2682–2689.

31Ackerman CM, Lowe LP, Lee H, et al.; The HAPO Study Cooperative Research Group: The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal size. J Clin Endocrinol Metab 2010;95:3242–3250.

32International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, et al.: International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–682.

33Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477–2486.

34Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009:361;1339–1348.

35Ryan EA: Diagnosing gestational diabetes. Diabetologia 2011;54:480–486.

36Long H: Diagnosing gestational diabetes: can expert opinions replace scientific evidence? Diabetologia 2011;54:2211–2213.

37Cundy T: Proposed new diagnostic criteria for gestational diabetes – a pause for thought? Diabet Med 2012;29:176–180.

38International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel Writing Group and the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Steering Committee, Metzger BE, Gabbe SG, Persson B: The diagnosis of gestational diabetes mellitus: new paradigms or status quo? J Matern Fetal Neonatal Med 2012;25:2564–2569.

39Langer O, Umans JG, Miodovnik M: The proposed GDM diagnostic criteria: a difference, to be a difference, must make a difference. J Matern Fetal Neonatal Med 2013;26:111–115.

40Kong JM, Lim K, Thompson DM: Evaluation of the International Association of the Diabetes in Pregnancy Study Group new criteria: gestational diabetes project. Can J Diabetes 2015;39:128–132.

41O’Sullivan EP, Avalos G, O’Reilly, Dennedy MC, Gaffney G, Dunne F: Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 2011;54:1640–1675.

42Bodmer-Roy S, Morin L, Cousineau J, Rey E: Pregnancy outcomes in women with and without gestational diabetes mellitus according to the International Association of the Diabetes and Pregnancy Study Groups Criteria. Obstet Gynecol 2012;120:746–752.

43Feldman RK, Tieu RS, Yasumura L: Gestational diabetes screening: The International Association of the Diabetes and Pregnancy Study Groups Compared with Carpenter-Coustan Screening. Obstet Gynecol 2016;127:10–17.

44Fuller KP, Borgida AF: Gestational diabetes mellitus screening using the one-step versus two-step method in a high-risk practice. Clin Diabetes 2014;32:148–150.

45Oriot P, Selvais P, Radikov J, Jacobs JL, Gilleman U, Loumaye R, Fernandez C: Assessing the incidence of gestational diabetes and neonatal outcomes using the IADPSG guidelines in comparison with the Carpenter and Coustan criteria in a Belgian general hospital. Acta Clin Belg 2014;69:8–11.

46Duran A, Sáenz S, Torrejón MJ, Bordiú E, Del Valle L, Galindo M, Perez N, Herraiz MA, Izquierdo N, Rubio MA, Runkle I, Pérez-Ferre N, Cusihuallpa I, Jiménez S, García de la Torre N, Fernández MD, Montañez C, Familiar C, Calle-Pascual AL: Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study. Diabetes Care 2014;37:2442–2450.

47Mayo K, Melamed N, Vandenberghe H, Berger H: The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. Am J Obstet Gynecol 2015;212:224.e1–e9.

48American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(suppl 1):S43–S48.

49Feig DS, Razzaq A, Sykora K, Hux JE, Anderson GM: Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes: a population-based study in Ontario, Canada, 1996–2001. Diabetes Care 2006;29:232–235.

50Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL: Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol 1997;177:1165–1171.

51Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R: Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynecol 2000;182:346–350.

52Maegawa Y, Sugiyama T, Kusaka H, Mitao M, Toyoda N: Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Res Clin Pract 2003;62:47–53.

53Yang X, Hsu-Hage B, Zhang H, Zhang C, Zhang Y, Zhang C: Women with impaired glucose tolerance during pregnancy have significantly poor pregnancy outcomes. Diabetes Care 2002;25:1619–1624.

54Boulet SL, Alexander GR, Salihu HM, Pass M: Macrosomic births in the United States: determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol 2003;188:1372–1378.

55Esakoff TF, Cheng YW, Sparks TN, Caughey AB: The association between birthweight 4000 gm or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Am J Obstet Gynecol 2009;672:E1–E4.

56Langer O, Yogev Y, Most O, Xenakis EM: Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005;192:989–997.

57Weiss PA, Haeusler M, Tamussino K, Haas J. Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000;107:1480–1485.

58Zhang X, Decker A, Platt RW, Kramer MS: How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol 2008;517:E1–E6.

59Sebire NJ, Jolly M, Harris JP, et al: Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes 2011;25:1175–1182.

60Kalter-Leibovici O, Freedman LS, Olmer L, et al: Screening and diagnosis of gestational diabetes mellitus: critical appraisal of the new International Association of Diabetes in Pregnancy Study Group recommendations on a national level. Diabetes Care 2012;35:1894–1896.

61Moyer VA; U.S. Preventive Services Task Force: Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;148:759–765.

62Scott DA, Loveman E, McIntyre L, Waugh N: Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol Assess 2002;6:1–161.

63The Canadian guide to clinical preventive health care/prepared by the Canadian Task Force on the Periodic Health Examination. Health Canada 1994;15–23.

64Chen Y, Quick WW, Yang W, Zhang Y, Baldwin A, Moran J, Moore V, et al: Cost of gestational diabetes mellitus in the United States in 2007. Popul Health Manag 2009;12:165–174.

65Agarwal MM, Dhatt GS, Othman Y: Gestational diabetes in a tertiary care hospital: implications of applying the IADPSG criteria. Arch Gynecol Obstet 2012;286:373–378.

66Werner EF, Pettker CM, Zuckerwise L, et al: Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the diabetes and pregnancy study groups cost-effective? Diabetes Care 2012;35:529–535.

67Ohno MS, Sparks TN, Cheng YW, Caughey AB: Treating mild gestational diabetes mellitus: a cost-effectiveness analysis. Am J Obstet Gynecol 2011;205:282.e1–e7.

68Mission JF, Ohno MS, Cheng YW, Caughey AB: Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 2012;207:326:e1–e1329.

69Hung TH, Hsieh TT: The effects of implementing the International Association of Diabetes and Pregnancy Study Groups criteria for diagnosing gestational diabetes on maternal and neonatal outcomes. PLoS One 2015;10:e0122261.

70Farrar D, Duley L, Medley N, Lawlor DA: Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev 2015;8:CD007122.

71Yeral MI, Ozgu-Erdinc AS, Uygur D, Seckin KD, Karsli MF, Danisman AN: Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 2014;46:512–518.

72Sevket O, Ates S, Uysal O, Molla T, Dansuk R, Kelekci S: To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes mellitus. J Matern Fetal Neonatal Med 2014;27(1):36–41.

73Waters TP, Dyer AR, Scholtens DM, Dooley SL, Herer E, Lowe LP, Oats JJ, Persson B, Sacks DA, Metzger BE, Catalano PM; HAPO Cooperative Study Research Group: Maternal and neonatal morbidity for women who would be added to the diagnosis of GDM using IADPSG criteria: a secondary analysis of the hyperglycemia and adverse pregnancy outcome study. Diabetes Care 2016;39:2204–2210.

74World Health Organization. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. Geneva, WHO, 2013. www.who.int/diabetes/publications/HyperglycaemiaInPregnancy/en/.

75Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, Cabero Roura L, McIntyre HD, Morris JL, Divakar H: The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 2015;131(suppl 3):S173–S211.

76American Diabetes Association: Standards of medical care in diabetes – 2011. Diabetes Care 2011;34(suppl 1):S11–S61.

77Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Murad MH, Yogev Y: Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013;98:4227–4249.

78Horvath K, Koch K, Jeitler K, Matyas E, Bender R, Bastian H, et al: Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ 2010;340:c1395.

79Standards of Medical Care in Diabetes: 2014 Position statement. Diabetes Care 2014;37:S20.

80American Diabetes Association: Classification and diagnosis of diabetes. Diabetes Care 2017;40(suppl 1):S11–S24.

81Vandorsten JP, Dodson WC, Espeland MA, Grobman WA, Guise JM, Mercer BM, et al: NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 2013;29:1–31.

82Committee opinion no. 504: Screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 2011;118:751–753.

83Committee on Practice Bulletins – Obstetrics. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol 2018;131:e49–e64.

84American Diabetes Association’s 77th Scientific Sessions; June 9–13, 2017, San Diego, California. https://diabetes.medicinematters.com/pregnancy/gestational-diabetes/hapo-fus-shows-persistent-ill-effects-of-maternal-­diabetes/12358110.

Prof. Eran Hadar, MD

Helen Schneider Hospital for Women, Rabin Medical Center

39 Zabotinski Street

IL–4941492 Petach-Tikva (Israel)

E-Mail eranh42@gmail.com